NO154918C
(no)
*
|
1977-08-27 |
1987-01-14 |
Bayer Ag |
Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
|
DE2830469A1
(de)
*
|
1978-07-11 |
1980-01-24 |
Bayer Ag |
Herstellung von l-desoxy-nojirimycin und n-substituierten derivaten
|
DE2835069A1
(de)
*
|
1978-08-10 |
1980-02-21 |
Bayer Ag |
N-amino-3,4,5-trihydroxypiperidine, ihre herstellung und verwendung
|
DE2839309A1
(de)
*
|
1978-09-09 |
1980-03-27 |
Bayer Ag |
3,4,5-trihydroxypiperidin-derivate
|
DE2848117A1
(de)
*
|
1978-11-06 |
1980-05-14 |
Bayer Ag |
Derivate des 2-hydroxymethyl-3,4,5- trihydroxy-piperidins, ihre herstellung und verwendung zur beeinflussung des kohlenhydrat- und fettstoffwechsels
|
JPS55118415A
(en)
*
|
1979-02-28 |
1980-09-11 |
Pii Papahadojiyopo Dometoriosu |
Method of encapsulating biologically active substance in lipoid cell
|
DE2925943A1
(de)
*
|
1979-06-27 |
1981-01-29 |
Bayer Ag |
1-alkadien-2,4-yl-2-hydroxymethyl3,4,5-trihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
DE2942365A1
(de)
*
|
1979-10-19 |
1981-05-14 |
Bayer Ag, 5090 Leverkusen |
2-hydroxyalkyl-3,4,5-trihydroxy-(pi)-peridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
|
JPS56108767A
(en)
*
|
1980-01-28 |
1981-08-28 |
Nippon Shinyaku Co Ltd |
Bismoranoline derivative
|
JPS56108768A
(en)
*
|
1980-01-28 |
1981-08-28 |
Nippon Shinyaku Co Ltd |
Cinnamylmoranoline derivative
|
DE3007078A1
(de)
*
|
1980-02-26 |
1981-09-10 |
Bayer Ag, 5090 Leverkusen |
Neue derivate von 3,4,5-trihydroxypiperidin, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel sowie in der tierernaehrung
|
DE3620645A1
(de)
*
|
1985-12-20 |
1987-07-02 |
Bayer Ag |
3-amino-4,5-dihydroxypiperidine, verfahren zu ihrer herstellung und ihre verwendung
|
US5192772A
(en)
*
|
1987-12-09 |
1993-03-09 |
Nippon Shinyaku Co. Ltd. |
Therapeutic agents
|
US5089520A
(en)
*
|
1987-12-21 |
1992-02-18 |
Monsanto Company |
Method of inhibiting virus
|
US4999360A
(en)
*
|
1987-12-21 |
1991-03-12 |
Monsanto Company |
Method of inhibiting virus
|
US4849430A
(en)
*
|
1988-03-09 |
1989-07-18 |
Monsanto Company |
Method of inhibiting virus
|
EP0344383A1
(fr)
*
|
1988-06-02 |
1989-12-06 |
Merrell Dow Pharmaceuticals Inc. |
Inhibiteurs d'alpha-glucosidase
|
US5043416A
(en)
*
|
1988-09-26 |
1991-08-27 |
Monsanto Company |
Method of inhibiting virus
|
US4937357A
(en)
*
|
1988-11-03 |
1990-06-26 |
G. D. Searle & Co. |
Intermediates for antiviral compounds
|
US4973602A
(en)
*
|
1988-11-03 |
1990-11-27 |
G. D. Searle & Co. |
Antiviral compounds and a method of use thereas
|
US5310745A
(en)
*
|
1988-11-03 |
1994-05-10 |
G. D. Searle & Co. |
Antiviral compounds
|
US5144037A
(en)
*
|
1988-11-03 |
1992-09-01 |
G. D. Searle & Co. |
1,5-dideoxy-1,5-imino-d-glucitol derivatives
|
US4876268A
(en)
*
|
1988-11-03 |
1989-10-24 |
G. D. Searle & Co. |
Antiviral compounds and use thereof
|
US5003072A
(en)
*
|
1988-11-03 |
1991-03-26 |
G. D. Searle & Co. |
1,5-dideoxy-1,5-imino-D-glucitol derivatives
|
US5221746A
(en)
*
|
1988-11-03 |
1993-06-22 |
G. D. Searle & Co. |
1,5-dideoxy-1,5-imino-D-glucitol derivatives
|
US4957926A
(en)
*
|
1988-12-22 |
1990-09-18 |
Monsanto Company |
Method of treating herpesviruses
|
US5103008A
(en)
*
|
1989-08-17 |
1992-04-07 |
Monsanto Company |
Compound, N-butyl-deoxynojirimycin-6-phosphate
|
US5043273A
(en)
*
|
1989-08-17 |
1991-08-27 |
Monsanto Company |
Phosphorylated glycosidase inhibitor prodrugs
|
EP0453692A1
(fr)
*
|
1990-04-27 |
1991-10-30 |
Merrell Dow Pharmaceuticals Inc. |
Nouveaux dérivés de nojirimycine
|
US5536732A
(en)
*
|
1990-04-27 |
1996-07-16 |
Merrell Pharmaceuticals Inc. |
N-derivatives of 1-deoxy nojirimycin
|
US5252587A
(en)
*
|
1990-04-27 |
1993-10-12 |
Merrell Dow Pharmaceuticals, Inc. |
N-derivatives of 1-deoxy nojirimycin
|
US5151519A
(en)
*
|
1990-05-07 |
1992-09-29 |
G. D. Searle & Co. |
Process for the preparation of 1,5-(alkylimino)-1,5-dideoxy-d-glucitol and derivatives thereof
|
US5504078A
(en)
*
|
1990-06-08 |
1996-04-02 |
Merrell Dow Pharmaceuticals Inc. |
α-glucosidase inhibitors
|
US5342951A
(en)
*
|
1992-04-01 |
1994-08-30 |
G.D. Searle & Co. |
2- and 3-sulfur derivatives of 1,5-iminosugars
|
US6291657B1
(en)
|
1993-05-13 |
2001-09-18 |
Monsanto Company |
Deoxygalactonojirimycin derivatives
|
US5798366A
(en)
*
|
1993-05-13 |
1998-08-25 |
Monsanto Company |
Method for treatment of CNS-involved lysosomal storage diseases
|
US5399567A
(en)
*
|
1993-05-13 |
1995-03-21 |
Monsanto Company |
Method of treating cholera
|
DK0739205T3
(da)
*
|
1994-01-13 |
2000-05-01 |
Searle & Co |
Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner
|
US20030100532A1
(en)
|
1997-02-14 |
2003-05-29 |
Gary S. Jacob |
Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
|
MY122499A
(en)
|
1997-11-10 |
2006-04-29 |
Searle & Co |
Use of alkylated iminosugars to treat multidrug resistance
|
US6689759B1
(en)
|
1998-02-12 |
2004-02-10 |
G. D. Searle & Co. |
Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
|
BR9907882A
(pt)
|
1998-02-12 |
2000-10-17 |
Searle & Co |
Uso de compostos de 1,5-didesóxi-1,5-imino-d-glucitol n-substituìdos para o tratamento de infecções de vìrus de hepatite
|
WO2001008672A2
(fr)
|
1999-02-12 |
2001-02-08 |
G.D. Searle & Co. |
Composes glucamine destines au traitement d'infections dues au virus de l'hepatite
|
US6545021B1
(en)
|
1999-02-12 |
2003-04-08 |
G.D. Searle & Co. |
Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
|
GB9909066D0
(en)
|
1999-04-20 |
1999-06-16 |
Oxford Glycosciences Uk Ltd |
Therapies
|
US20050032841A1
(en)
*
|
1999-04-20 |
2005-02-10 |
Steven Walkley |
Therapeutic compositions and methods of treating glycolipid storage related disorders
|
GEP20084406B
(en)
*
|
2003-05-30 |
2008-06-25 |
Ranbaxy Lab Ltd |
Substituted pyrrole derivatives and their use as hmg-co inhibitors
|
US8003617B2
(en)
*
|
2004-11-10 |
2011-08-23 |
Genzyme Corporation |
Methods of treating diabetes mellitus
|
AU2006313430B2
(en)
*
|
2005-11-08 |
2012-09-06 |
Ranbaxy Laboratories Limited |
Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt
|
AR059838A1
(es)
*
|
2006-03-14 |
2008-04-30 |
Ranbaxy Lab Ltd |
Formulaciones para dosis estabilizantes de estatina
|
PT2032134E
(pt)
|
2006-05-09 |
2015-10-07 |
Genzyme Corp |
Métodos de tratamento da doença do fígado gorduroso
|
CN101494980A
(zh)
*
|
2006-07-14 |
2009-07-29 |
兰贝克赛实验室有限公司 |
HMG-CoA还原酶抑制剂的多晶型形式及其应用
|
WO2008063727A2
(fr)
*
|
2006-08-21 |
2008-05-29 |
United Therapeutics Corporation |
Polytherapie destinée a traiter des infections virales
|
US8097728B2
(en)
*
|
2007-04-30 |
2012-01-17 |
Philadelphia Health & Education Corporation |
Iminosugar compounds with antiflavirus activity
|
EP2594565B1
(fr)
*
|
2007-05-31 |
2018-10-24 |
Genzyme Corporation |
Inhibiteurs de glucosylcéramide synthase de type 2-acylaminopropanol
|
EP2209473B1
(fr)
|
2007-10-05 |
2017-11-22 |
Genzyme Corporation |
Procédé utilisant des dérivés de céramide pour traiter des maladies polykystiques des reins
|
US8389517B2
(en)
|
2008-07-28 |
2013-03-05 |
Genzyme Corporation |
Glucosylceramide synthase inhibition for the treatment of collapsing glomerulopathy and other glomerular disease
|
MX2011003517A
(es)
|
2008-10-03 |
2011-05-25 |
Genzyme Corp |
Inhibidores de la glucosilceramida sintasa tipo 2-acilaminopropanol.
|
ES2579628T3
(es)
|
2009-02-23 |
2016-08-12 |
Emergent Virology Llc |
Iminoazúcares y métodos de tratamiento de enfermedades virales
|
JP5951996B2
(ja)
*
|
2009-02-24 |
2016-07-13 |
ユナイテッド セラピューティクス コーポレーション |
イミノ糖及びアレナウイルス感染症を治療する方法
|
JP5634510B2
(ja)
|
2009-06-12 |
2014-12-03 |
ユナイテッド セラピューティクス コーポレイション |
イミノ糖ならびにブニヤウイルスおよびトガウイルス疾患を治療する方法
|
ES2527623T3
(es)
*
|
2009-09-04 |
2015-01-27 |
United Therapeutics Corporation |
Iminoazúcares para su uso en el tratamiento de enfermedades por filovirus
|
WO2011028781A1
(fr)
*
|
2009-09-04 |
2011-03-10 |
United Therapeutics Corporation |
Procédés de traitement d'infections poxvirales
|
CN102625796B
(zh)
*
|
2009-09-04 |
2015-03-11 |
联合治疗公司 |
治疗正粘病毒感染的方法
|
WO2017192599A1
(fr)
|
2016-05-02 |
2017-11-09 |
Florida State University Research Foundation, Inc. |
Traitement des infections provoquées par le virus zika à l'aide d'inhibiteurs d'alpha-glucosidase
|
EP4106752A4
(fr)
|
2020-02-21 |
2024-03-20 |
Florida State University Research Foundation, Inc. |
Traitement d'infections à coronavirus humain à l'aide d'inhibiteurs de traitement de glycoprotéine alpha-glucosidase
|